Eczema Trial, Recruiting NCT06390696 Sponsor: Natural Resources Institute Finland Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT06390696
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your eczema is rated at a score of 2 or higher on a standard medical scale that measures how much of the body is affected and how severe the symptoms are (confirm with trial site).

Who may not be able to join:

  • Your eczema score is below 2 on the standard severity scale used by doctors.
  • You have a condition where your immune system does not work properly, such as an antibody deficiency.
  • You are currently taking medications that suppress or weaken your immune system.
  • You have a disease that affects how your immune system works, such as ulcerative colitis, rheumatoid arthritis, Crohn's disease, or diabetes.
  • You have been diagnosed with cancer.
  • You are using any creams, ointments, or other skin treatments specifically for eczema during the trial period.
  • You have a condition that affects your immune response, such as Down's syndrome.
  • You have not received the vaccines included in your country's standard national vaccination programme.
  • You are already taking part in another clinical trial or follow-up study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Aki Sinkkonen, Natural Resources Institute Finland

Phone: +358295322500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Natural Resources Institute Finland
Registry
ClinicalTrials.gov
Start date
26 May 2023
Est. completion
30 September 2027

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Eczema Area and Severity Index (EASI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov